Home » Newsletters » BioWorld Science

BioWorld Science

March 29, 2007

View Archived Issues

Snapshots on new candidates to reduce Abeta pathology in AD

Studies in vivo and in healthy volunteers support investigation of AT-2101

Snapshots: studies from the American College of Cardiology annual meeting

PRT-060128 well tolerated, well absorbed in phase I study

Recent patents describe new treatment options for diabetes

Novel antimitotics targeting the kinesin spindle protein presented at the ACS

Novel therapeutic agents for cardiovascular disorders reported in recent patent literature

Nesiritide study provides new renal and mortality safety data

Interim data suggest Nebido trial will meet endpoints

GSK's novel clinical candidate for the treatment of hepatitis C profiled at the ACS meeting

Tekturna and Diovan in combination produce improved blood pressure reduction

Recent Banyu and Lilly patents disclose novel antiobesity agents

Pramiconazole demonstrates efficacy in tinea versicolor

VEGF Trap-Eye improves retinal thickness and visual acuity in wet AMD

Weekly PC-DAC:Exendin-4 lowers blood glucose in type 2 diabetes

New data on gonadotropin-releasing hormone receptor blockers presented

Eltrombopag increases platelet counts in idiopathic thrombocytopenic purpura

OncoGel studied in phase I/II GBM study

Inovio's DNA delivery technology enhances potency of HIV DNA vaccine

FDA approves product enhancements for BeneFIX coagulation factor IX

Preclinical data for deCODE's DG-051 reported at the ACS meeting

Terameprocol studied in phase I/II trial for brain tumors

SSA-426: a novel antidepressant with dual activity on the 5-HT transporter and the 5-HT1A receptor

Resverlogix advances IND preparations for RVX-208

Botox to be studied for paroxysmal trigeminal neuralgia pain

rNAPc2 receives fast track designations in metastatic colorectal cancer

Preliminary phase III plan outlined for faropenem

Polyphenon E Ointment filed in European countries

Avastin approved in E.U. for first-line metastatic breast cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...